TARGESON, LLC

Basic Information

850 CARLINS WAY
CHARLOTTESVILLE, VA, 22903-7666

Company Profile

n/a

Additional Details

Field Value
DUNS: 610945474
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Contrast agents for high-sensitivity ultrasound molecular imaging of tumor angiog

    Amount: $195,662.00

    DESCRIPTION (provided by applicant): Molecular imaging techniques have strong potential in the setting of preclinical research, primarily for drug discovery and basic science in the field of cancer re ...

    SBIR Phase I 2011 Department of Health and Human Services
  2. Novel Microparticle Contrast Agent for Near Infrared Molecular Imaging

    Amount: $177,726.00

    DESCRIPTION (provided by applicant): Molecular imaging techniques have demonstrated efficacy in the setting of preclinical research, primarily for drug discovery and basic science. Optical imaging has ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Ultrasound mediated targeted therapy for kidney disease

    Amount: $166,046.00

    DESCRIPTION (provided by applicant): Antibodies can be used diagnostically as ligands for molecular imaging, and also as therapeutic to neutralize factors involved in the development of kidney disease ...

    SBIR Phase I 2009 Department of Health and Human Services
  4. Ultrasound Contrast Agents for Inflammation and Angiogenesis

    Amount: $1,030,150.00

    DESCRIPTION (provided by applicant): Site-targeted microbubbles (MB) have demonstrated potential as a molecular imaging tool. A new targeted MB platform was developed in phase I of this project. This ...

    SBIR Phase II 2009 Department of Health and Human Services
  5. Multi-Targeted Contrast Ultrasound Agent for Imaging Angiogenesis

    Amount: $104,679.00

    DESCRIPTION (provided by applicant): Targeson has developed and commercialized a microbubble contrast agent that is suitable for conjugation to an array of molecular targeting ligands via an avidin/bi ...

    SBIR Phase I 2008 Department of Health and Human Services
  6. Ultrasound Contrast Agents for Inflammation and Angiogenesis

    Amount: $99,729.00

    DESCRIPTION (provided by applicant): We propose to develop molecular imaging probes for imaging angiogenesis and inflammation using contrast-enhanced ultrasound. These probes are gas-encapsulated micr ...

    SBIR Phase I 2008 Department of Health and Human Services
  7. Gene Delivery Agents for Ultrasound-Mediated Transfection

    Amount: $99,867.00

    DESCRIPTION (provided by applicant): We propose to develop a novel acoustically activated microbubble gene delivery vehicle for treatment of experimental inflammatory bowel disease. Microbubble ultras ...

    SBIR Phase I 2007 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government